surmount 4 tirzepatide Shifts in body mass index category with and associated changes in cardiometabolic risk factors in people with obesity: a post hoc analysis from the SURMOUNT-1 and SURMOUNT-4 trials Tirzepatide Demonstrates Sustained Weight Loss

A few points worth knowing: DPP-4 resistance: Tirzepatide's aminoisobutyric acid (Aib) substitutions at positions 2 and 13 block the primary DPP-4 enzymatic cleavage site

One study posited that a GHK-Cu possibly reduces visible bioindicators, improving skin laxity and clarity

In support, Li et al

Wegovy, Semaglutide & Tirzepatide: A Medical Weight Loss Guide Medical weight loss has advanced significantly in recent years, offering patients more effective and personalized options than ever before

Weight regain after discontinuation of OMMs Four trials reported information on weight regain after OMM discontinuation (one each for liraglutide 31 and tirzepatide 33 and two for semaglutide 34,35 )